Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
- 28 February 2023
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (8) , 2542-2546
Abstract
No abstract availableKeywords
Funding Information
- Mayo Foundation for Medical Education and Research
This publication has 27 references indexed in Scilit:
- Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematologyEuropean Journal of Clinical Investigation, 2009
- Survey of aspirin administration in systemic mastocytosisProstaglandins & Other Lipid Mediators, 2009
- Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxisClinical & Experimental Allergy, 2009
- Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 ProductionInternational Archives of Allergy and Immunology, 2008
- Emergency department anaphylaxis: A review of 142 patients in a single yearJournal of Allergy and Clinical Immunology, 2001
- Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjectsProstaglandins, Leukotrienes and Essential Fatty Acids, 1991
- Biochemical Diagnosis of Systemic Mast Cell DisordersJournal of Investigative Dermatology, 1991
- Glucagon Reversal of Hypotension in a Case of Anaphylactoid ShockAnnals of Internal Medicine, 1986
- Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.Journal of Clinical Investigation, 1983
- Inhibition of basophil histamine release by anti-inflammatory steroidsNature, 1981